Technology
Health
Pharmaceutical

Xeris Pharmaceuticals

$11.37
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.35 (-2.99%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell XERS and other stocks, options, ETFs, and crypto commission-free!

About

Xeris Pharmaceuticals, Inc.is a pharmaceutical company, which develops and commercializes ready-to-use, liquid-stable injectables. It offers XeriSolâ„¢ and XeriJectâ„¢ formulation technologies. Read More The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Austin, TX.

Employees
90
Headquarters
Chicago, Illinois
Founded
2005
Market Cap
315.04M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
147.03K
High Today
$11.84
Low Today
$11.10
Open Price
$11.84
Volume
63.24K
52 Week High
$27.98
52 Week Low
$8.67

Collections

Technology
Health
Pharmaceutical
2018 IPO
US
North America

News

Yahoo FinanceMay 9

Xeris Pharmaceuticals Announces First Quarter 2019 Financial Results and Highlights Its Pipeline

130
Markets InsiderApr 26

Xeris Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CHICAGO, April 26, 2019 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, today announced that on April 24, 2019, the Compensation Committee of Xeris’ Board of Directors granted non-qualified stock options for an aggregate of 73,000 shares of its common stock to eight new employees under Xeris’ Inducement Equity Plan. Xeris’ Induc...

112

Earnings

-$1.07
-$0.95
-$0.83
-$0.71
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Aug 12, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.